Testosterone Enanthate Self-Injection Technique: A Complete Clinical Guide

HealthRX.com

The label names deep gluteal injection, not self-injection steps

50 to 400 mgLabeled dose for male hypogonadism, given every 2 to 4 weeksSource: dailymed.nlm.nih.gov

Print or save as PDF

Key numbers

  • 400 mgMonthly total above which extra doses are not required, per the labelSource: dailymed.nlm.nih.gov, as cited Nov 7, 2026
  • 17%Share of IM injections in overweight/obese adults given within ACIP guidelines (study of 22 women)Source: pubmed.ncbi.nlm.nih.gov, as cited Nov 7, 2026
  • 4.0 percentMean hematocrit rise vs placebo with IM testosterone enanthate or cypionate (29 trials, 3,393 men)Source: pubmed.ncbi.nlm.nih.gov, as cited Nov 7, 2026

See the public record for Testosterone enanthate

At a glance

  • Route / Deep gluteal intramuscular injection, given slowly [1]
  • Labeled dose / 50 to 400 mg every 2 to 4 weeks [1]
  • Monthly maximum / Total doses above 400 mg per month are not required [1]
  • Injection frequency / More often than every 2 weeks rarely indicated [1]
  • Self-injection / Not described in the prescribing information [1]
  • Monitoring / Testosterone, hematocrit and prostate cancer risk in the first year per Endocrine Society [2]

What the label says about the injection

Before treatment, the label says to confirm hypogonadism with morning serum testosterone measured on at least two separate days, both below the normal range [1]. For male hypogonadism, the suggested dose is 50 to 400 mg every 2 to 4 weeks. Total doses above 400 mg per month are not required because of the prolonged action of the preparation, and injections more often than every 2 weeks are rarely indicated [1].

The administration instruction is specific about route and speed: inject slowly, deep into the gluteal muscle, following usual intramuscular precautions such as avoiding intravascular injection [1]. The label's administration paragraph does not give a needle gauge, needle length, aspiration step or site rotation schedule [1].

Reaching the muscle

The labeled site is the gluteal muscle [1]. A general review of intramuscular injection notes that IM injection is not a benign procedure and that unsafe practices can cause significant morbidity; it presents a guideline for evidence-based technique to limit injury and discomfort [3]. A study of 22 adult women found that 17% of injections in overweight and obese patients were given within ACIP guidelines, and concluded that the needle length used is often too short in overweight and obese individuals [4]. These findings are about IM injections generally, not a tested testosterone enanthate self-injection protocol.

Questions worth asking

Choose the questions you want to keep

Nurse Scott on giving an intramuscular injection with little pain

Nurse Scott argues that intramuscular injections can be given with far less pain than most people expect, and he credits the result to technique. He recommends choosing the outer middle part of the thigh, cleaning the skin, and letting the alcohol dry first. His main advice is to stretch the skin before inserting the needle, to jab quickly like a dart, and to cough at the moment of insertion so the brain is distracted from the pinch. He presents these tips from his own years of giving shots, and he frames the method as especially useful for people who fear starting hormone injections. He also stresses that this technique is for intramuscular shots, not subcutaneous ones like insulin.

Who is speaking?

Nurse Scott. Nurse, as named on the channel and in the video Background

Episode notes and full video

Side effects and monitoring

The label lists inflammation and pain at the injection site as adverse reactions [1]. It also lists polycythemia and venous thromboembolism, and says to discontinue treatment if a venous thromboembolic event is suspected [1]. The label says testosterone can increase blood pressure, that blood pressure should be monitored periodically, and that testosterone products are not recommended in patients with uncontrolled hypertension [1].

In a network meta-analysis of 29 placebo-controlled trials and 3,393 men, intramuscular testosterone enanthate or cypionate raised mean hematocrit by 4.0 percent versus placebo [5]. The Endocrine Society recommends monitoring symptoms, serum testosterone, hematocrit, and prostate cancer risk during the first year [2].

Interactions and contraindications

The label says patients on oral anticoagulants need close monitoring when androgens are started or stopped [1]. In diabetic patients, androgens may lower blood glucose and insulin requirements [1]. With corticosteroids or ACTH, the label warns of an enhanced tendency toward edema and says to use caution, especially in patients with hepatic or cardiac disease [1]. Oxyphenbutazone levels may rise [1]. The label contraindicates testosterone enanthate in men with breast cancer or known or suspected prostate cancer, in women who are or may become pregnant, and in anyone with hypersensitivity to a component [1].

Check what you know

Think you have it? Try 4 quick questions and see what the article says.

1. According to the label, which route and speed does the administration instruction specify for testosterone enanthate?

Question 1 of 4

Score: 0 right, 0 of 4 answered

Frequently asked questions

Where does the label say to inject testosterone enanthate?
Deep into the gluteal muscle, slowly, with usual intramuscular precautions and avoidance of intravascular injection [1].
Does the label give self-injection steps?
No. Its administration paragraph covers deep gluteal intramuscular injection but does not give patient self-injection instructions, needle gauge, needle length, aspiration steps, or a site rotation schedule [1].
What dose does the label recommend?
50 to 400 mg every 2 to 4 weeks for male hypogonadism [1].
What injection-site reactions does the label list?
Inflammation and pain at the injection site are listed adverse reactions [1].
What should be monitored during treatment?
The Endocrine Society recommends monitoring symptoms, serum testosterone, hematocrit, and prostate cancer risk in the first year [2]. The label says to monitor blood pressure periodically [1].
Can testosterone enanthate be injected into the thigh?
The site named in the label is the gluteal muscle [1].

References

Show all 6 referencesHide references
  1. U.S. National Library of Medicine, DailyMed. Testosterone enanthate injection USP intramuscular, Hikma prescribing information. Testosterone enanthate injection USP intramuscular, Hikma label
  2. Bhasin S, Brito JP, Cunningham GR, Hayes FJ, Hodis HN, Matsumoto AM, et al. Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2018;103(5):1715-1744.
  3. Nicoll LH, Hesby A. Intramuscular injection: an integrative research review and guideline for evidence-based practice. Appl Nurs Res. 2002;15(3):149-62.
  4. Palma S, Strohfus P. Are IM injections IM in obese and overweight females? A study in injection technique. Appl Nurs Res. 2013;26(4):e1-4.
  5. Nackeeran S, Kohn T, Gonzalez D, White J, Ory J, Ramasamy R. The Effect of Route of Testosterone on Changes in Hematocrit: A Systematic Review and Bayesian Network Meta-Analysis of Randomized Trials. J Urol. 2022;207(1):44-51.
  6. Nurse Scott. Painless Self Injection - 1.4 M Views!. Accessed 2026-11-11.
Evidence overview for Testosterone Enanthate Self-Injection Technique: A Complete Clinical Guide